These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16312345)

  • 1. Evaluation of ofloxacin activity against recent clinical isolates.
    Nani E; Anzivino D; Lavitola A; Lembo M; Covelli B
    J Chemother; 1989 Jul; 1(4 Suppl):145-6. PubMed ID: 16312345
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS; Talboys CA; Roberts AP
    J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract]   [Full Text] [Related]  

  • 3. Ofloxacin in open fractures.
    Ketterl R; Beckurts T; Stübinger B; Machka K; Claudi B
    J Chemother; 1989 Jul; 1(4 Suppl):737-8. PubMed ID: 16312615
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of bacterial isolates from corneal specimens and their antibiotic resistance profile.
    Begum NN; Al-Khattaf AS; Al-Mansouri SM; Yeboah EA; Kambal AM
    Saudi Med J; 2006 Jan; 27(1):41-5. PubMed ID: 16432592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide assessment of the activity of cefotetan against clinical isolates.
    Turner PJ; Edwards JR
    J Chemother; 1989 Jul; 1(4 Suppl):97-8. PubMed ID: 16312321
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of antibacterial activity of norfloxacin and ofloxacin in vitro by serum and experimental pleural exudates.
    Miglioli PA; Sartore P; Gianfranceschi L; Lanzafame P; Berti T
    J Chemother; 1989 Jul; 1(4 Suppl):140-1. PubMed ID: 16312342
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriological and clinical experiences with ofloxacin in urinary tract infections.
    Fröhlich G; Stratmeyer R
    Chemioterapia; 1987 Jun; 6(2 Suppl):525-6. PubMed ID: 3509489
    [No Abstract]   [Full Text] [Related]  

  • 8. The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae.
    Hammerschlag MR; Roblin PM
    J Antimicrob Chemother; 2004 Jul; 54(1):281-2. PubMed ID: 15190026
    [No Abstract]   [Full Text] [Related]  

  • 9. The bactericidal activity of ofloxacin against staphylococci.
    Lewin CS; Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):151-3. PubMed ID: 16312348
    [No Abstract]   [Full Text] [Related]  

  • 10. Ofloxacin.
    Med Lett Drugs Ther; 1991 Jul; 33(849):71-3. PubMed ID: 2067462
    [No Abstract]   [Full Text] [Related]  

  • 11. An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Segatore B; Perilli M; Larosa M; Setacci D; Celenza G; Amicosante G
    Int J Antimicrob Agents; 2007 Oct; 30(4):374-6. PubMed ID: 17659863
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
    Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibacterial activity of tobramycin].
    Acar JF
    Nouv Presse Med; 1974 Apr; 3(0):57-9. PubMed ID: 4600179
    [No Abstract]   [Full Text] [Related]  

  • 14. ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia.
    Morrissey I; Biek D; Janes R
    J Antimicrob Chemother; 2009 Jul; 64(1):209-10. PubMed ID: 19429928
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of the postantibiotic effect of ofloxacin on gram-negative bacteria utilizing a new method.
    Nilsson L; Isaksson B; Maller R; Nilsson M
    J Chemother; 1989 Jul; 1(4 Suppl):149-51. PubMed ID: 16312347
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of ertapenem and comparators against recent clinical isolates from intra-abdominal abscesses (SMART 2009).
    Hawser SP
    J Infect; 2011 Jun; 62(6):496-7. PubMed ID: 21458487
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
    Balkhy HH; Memish ZA; Shibl A; Elbashier A; Osoba A
    East Mediterr Health J; 2005; 11(1-2):36-44. PubMed ID: 16532669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity of levofloxacin against Mycoplasma pneumoniae.
    Duffy LB; Crabb DM; Bing X; Waites KB
    J Antimicrob Chemother; 2003 Sep; 52(3):527-8. PubMed ID: 12888583
    [No Abstract]   [Full Text] [Related]  

  • 19. Invasive Haemophilus influenzae isolates with decreased levofloxacin susceptibility in Hong Kong.
    Ho PL; Mak GC; Tse CW; Chow KH; Cheung CH
    J Antimicrob Chemother; 2006 Feb; 57(2):366. PubMed ID: 16387750
    [No Abstract]   [Full Text] [Related]  

  • 20. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.